Skip to main content
Log in

Therapie der Mitralklappeninsuffizienz

Chirurgische und interventionelle Neuerungen

Treating mitral regurgitation

A surgical and interventional update

  • Schwerpunkt/CME
  • Published:
Herz Aims and scope Submit manuscript

Zusammenfassung

In der Therapie der Mitralklappeninsuffizienz (MI) hat sich die rekonstruktive Klappenchirurgie zum Goldstandard entwickelt. Diese ist dem prothetischen Klappenersatz hinsichtlich der perioperativen Komplikationsraten und der Langzeitergebnisse deutlich überlegen. Zudem setzt sich zunehmend ein minimal-invasives chirurgisches Vorgehen durch, welches das operative Trauma reduziert und dem konventionellen Eingriff im Ergebnis mindestens ebenbürtig ist. Allerdings bleibt die Operation einer wachsenden Zahl von Patienten verwehrt. Hierbei handelt es sich v. a. um ältere Patienten mit reduzierter Ventrikelfunktion und funktioneller MI, die häufig relevante Komorbiditäten aufweisen. Für diese Patienten können katheterbasierte Mitralklappentherapien eine gute Alternative zum chirurgischen Vorgehen darstellen. Die meisten der neuen interventionellen Techniken befinden sich in experimentellen oder frühen klinischen Entwicklungsstadien. Einzig mit dem MitraClip®-System, welches eine interventionelle Segelplastik ermöglicht, besteht inzwischen umfassende klinische Erfahrung. Für den Erfolg eines patientenorientierten Mitralklappenprogramms ist die Integration chirurgischer und interventioneller Verfahren an einem Herzzentrum maßgeblich. Die Bildung eines interdisziplinären sog. „Heart-Teams“, das sich aus Kardiologen und Herzchirurgen zusammensetzt, ist hierfür von entscheidender Bedeutung.

Abstract

Surgical mitral valve repair has constantly evolved to become the standard of care for severe mitral regurgitation (MR) with superior acute and long-term results compared to valve replacement. Minimally-invasive surgical techniques have been successful in reducing operative trauma while yielding equivalent or even superior results compared to the conventional sternotomy approach. However, due to elevated operative risk a growing proportion of patients are not referred for surgery, especially elderly patients with reduced ventricular function and functional MR who often present with relevant comorbidities. It is for these patients that transcatheter-based therapies may represent an attractive option. While most interventional techniques are still in experimental or early clinical stages of development, relevant clinical experience has been gained with the MitraClip® device. For successful implementation of a patient-centered mitral valve program, integration of surgical and interventional treatment modalities within a heart center is of paramount importance. This is best accomplished by an interdisciplinary dedicated heart team consisting of cardiologists and cardiac surgeons.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6
Abb. 7
Abb. 8
Abb. 9

Literatur

  1. Nkomo VT, Gardin JM, Skelton TN et al (2006) Burden of valvular hear diseases: a population-based study. Lancet 368:1005–1011

    Article  PubMed  Google Scholar 

  2. Rosamond W, Flegal K, Furie K et al (2008) Heart disease and stroke statistics – 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117:e25–e146

    Article  PubMed  Google Scholar 

  3. Carpentier A (1983) Cardiac valve surgery – the „Frenche correction“. J Thorac Cardiovasc Surg 86:323–337

    PubMed  CAS  Google Scholar 

  4. David TE, Ivanov J, Armstrong S, Rakowski H (2003) Late outcomes of mitral valve repair for floppy valves: implications for asymptomatic patients. J Thorac Cardiovasc Surg 125:1143–1152

    Article  PubMed  Google Scholar 

  5. Conradi L, Treede H, Deuse T et al (2010) Minimally-invasive mitral valve surgery: evolution of the technique to the standard of care for mitral repair. J Thorac Cardiovasc Surg 58(Suppl 1):119

    Google Scholar 

  6. Mirabel M, Iung B, Baron G et al (2007) What are the characteristics fo patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 28:1358–1365

    Article  PubMed  Google Scholar 

  7. Gilbert BW, Schatz RA, VonRamm OT et al (1976) Mitral valve prolapse. Two-dimensional echocardiographic and angiographic correlation. Circulation 54:716–723

    PubMed  CAS  Google Scholar 

  8. Wu AH, Aaronson KD, Bolling SF et al (2005) Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 45:381–387

    Article  PubMed  Google Scholar 

  9. Bonow RO, Carabello BA, Chatterjee K et al (2008) 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 52:e1–e142

    Article  PubMed  Google Scholar 

  10. Vahanian A, Baumgartner H, Bax J et al (2007) Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European Society of Cardiology. Eur Heart J 28:230–268

    PubMed  Google Scholar 

  11. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D et al (2005) Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 352:875–883

    Article  PubMed  CAS  Google Scholar 

  12. Iung B, Gohlke-Bärwolf C, Tornos P et al (2002) Recommendations on the management of the asymptomatic patient with valvular heart disease. Eur Heart J 23:1253–1266

    Article  PubMed  CAS  Google Scholar 

  13. Kang DH, Kim JH, Rim JH et al (2009) Comparison of early versus conventional treatment in asymptomatic severe mitral regurgitation. Circulation 119:797–804

    Article  PubMed  Google Scholar 

  14. Montant P, Chenot F, Robert A et al (2009) Long-term survival in asymptomatic patients with severe degenerative mitral regurgitation: a propensity score-based comparison between an early surgical strategy and a conservative treatment approach. J Thorac Cardiovasc Surg 138:1339–1348

    Article  PubMed  Google Scholar 

  15. Topilsky Y, Suri R, Schaff HV, Enriquez-Sarano M (2010) When to intervene for asymptomatic mitral valve regurgitation. Semin Thoracic Cardiovasc Surg 22:216–224

    Article  Google Scholar 

  16. Lawrie GM (1998) Mitral valve repair vs replacement. Current recommendations and long-term results. Cardiol Clin 16:437–448

    Article  PubMed  CAS  Google Scholar 

  17. Mohty D, Orszulak TA, Schaff HV et al (2001) Very long-term survival and durability of mitral valve repair for mitral valve prolapse. Circulation 104:I1-I7

    Article  PubMed  CAS  Google Scholar 

  18. Perier P, Hohenberger W, Lakew F et al (2008) Toward a new paradigm for the reconstruction of posterior leaflet prolapse: midterm results of the „respect rather than resect“ approach. Ann Thorac Surg 86:718–725

    Article  PubMed  Google Scholar 

  19. Alfieri O, Maisano F, De Bonis M et al (2001) The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 22:674–681

    Article  Google Scholar 

  20. David TE, Armstrong S, Sun Z (1995) Left ventricular function after mitral valve surgery. J Heart Valve Dis 4(Suppl2):175–180

    Google Scholar 

  21. Modi P, Hassan A, Chitwood WR Jr (2008) Minimally invasive mitral valve surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg 34:943–952

    Article  PubMed  Google Scholar 

  22. Mihaljevic T, Cohn LH, Unic D et al (1994) One thousand minimally invasive valve operations: early and late results. Ann Thorac Surg 240:529–534

    Google Scholar 

  23. Reichenspurner H, Detter C, Deuse T et al (2005) Video and robotic-assisted minimally invasive mitral valve surgery: a comparison of the Port-Access and transthoracic clamp techniques. Ann Thorac Surg 79:485–490

    Article  PubMed  Google Scholar 

  24. Bach DS, Bolling SF (1996) Improvement following correction of secondary mitral regurgitation in end-stage cardiomyopathy with mitral annuloplasty. Am J Cardiol 78:966–969

    Article  PubMed  CAS  Google Scholar 

  25. Mihaljevic T, Lam BK, Rajeswaran J et al (2007) Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol 49:2191–2201

    Article  PubMed  Google Scholar 

  26. Schofer J, Siminiak T, Haude M et al (2009) Percutaneous mitral annuloplasty for functional mitral regurgitation. Circulation 120:326–333

    Article  PubMed  Google Scholar 

  27. Chiam PTL, Ruiz CE (2011) Percutaneous transcatheter mitral valve repair: a classification of the technology. J Am Coll Cardiol Intv 4:1–13

    Google Scholar 

  28. Harnek J, Webb JG, Kuck KH et al (2011) Transcatheter implantation of the MONARC coronary sinus device for mitral regurgitation: 1-year results from the EVOLUTION phase I study (Clinical Evaluation of the Edwards Lifesciences Percutaneous Mitral Annuloplasty System for the Treatment of Mitral Regurgitation). JACC Cardiovasc Interv 4:115–122

    Article  PubMed  Google Scholar 

  29. Sack S, Kahlert P, Bilodeau L et al (2009) Percutaneous transvenous mitral annuloplasty: initial human experience. Circ Cardiovasc Interv 2:277–284

    Article  PubMed  Google Scholar 

  30. Choure AJ, Garcia MJ, Hesse B et al (2006) In vivo analysis of the anatomical relationship of coronary sinus to mitral anulus and left circumflex coronary artery using cardiac multidetector computed tomography: implications for percutaneous coronary sinus mitral annuloplasty. J Am Coll Cardiol 48:1938–1945

    Article  PubMed  Google Scholar 

  31. Tops LF, Van de Veire NR, Schuijf JD et al (2007) Noninvasive evaluation of coronary sinus anatomy and its relation to the mitral valve annulus: implications for percutaneous mitral annuloplasty. Circulation 115:1426–1432

    Article  PubMed  Google Scholar 

  32. Lansac E, Di Centa I, Al Attar N et al (2008) Percutaneous mitral annuloplasty through the coronary sinus: an anatomic point of view. J Thorac Cardiovasc Surg 135:376–381

    Article  PubMed  Google Scholar 

  33. Feldman T, Wasserman HS, Herrmann HC et al (2005) Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I clinical trial. J Am Coll Cardiol 46:2134–2140

    Article  PubMed  Google Scholar 

  34. Feldman T, Kar S, Rinaldi M et al (2009) Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge Repair Study) cohort. J Am Coll Cardiol 54:686–694

    Article  PubMed  Google Scholar 

  35. Feldman T, Foster E, Glower DD et al (2011) Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 364:1395–1406

    Article  PubMed  CAS  Google Scholar 

  36. Franzen O, Baldus S, Rudolph V et al (2010) Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J 31:1373–1381

    Article  PubMed  Google Scholar 

  37. Rudolph V, Knap M, Franzen O et al (2011) Echocardiographic and clinical outcomes of MitraClip therapy in patients not amenable to surgery. J Am Coll Cardiol [accepted for publication]

  38. Conradi L, Treede H, Franzen O et al (2011) Impact of MitraClip™ therapy on secondary mitral valve surgery in patients at high surgical risk. Eur J Cardiothorac Surg Apr 14 [Epub ahead of print]

  39. Gummert JF, Funktat AK, Beckmann A et al (2011) Cardiac surgery in Germany during 2010: a report on behalft of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 59:259–267

    Article  PubMed  CAS  Google Scholar 

  40. Wijns W, Kolh P, Danchin N et al (2010) Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J 31:2501–2555

    Article  PubMed  Google Scholar 

  41. Holmes DR Jr, Mack MJ (2011) Transcatheter valve therapy a professional society overview from the American College of Cardiology Foundation and the Society of Thoracic Surgeons. J Am Coll Cardiol 58:445–455

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Keine Angaben.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Reichenspurner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Conradi, L., Treede, H., Baldus, S. et al. Therapie der Mitralklappeninsuffizienz. Herz 36, 677–685 (2011). https://doi.org/10.1007/s00059-011-3531-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00059-011-3531-7

Schlüsselwörter

Keywords

Navigation